Cargando…
Adverse Skin Reactions due to Ribavirin in Hepatitis C Combination Therapy with Pegylated Interferon-α(2a)
The introduction of ribavirin to hepatitis C combination therapy with pegylated interferon (PEG-IFN)-α(2a) has improved sustained responses, but it has been accompanied by an increased incidence of cutaneous side effects. Most cases of drug eruption caused by ribavirin and PEG-IFN-α(2) or IFN-α comb...
Autores principales: | Shindo, Masahisa, Terai, Isamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919427/ https://www.ncbi.nlm.nih.gov/pubmed/24516409 http://dx.doi.org/10.1159/000357516 |
Ejemplares similares
-
Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event
por: Quack, Henriette, et al.
Publicado: (2013) -
Primary Retroperitoneal Müllerian Adenocarcinoma: A Case Report and Literature Review
por: Spinelli, C., et al.
Publicado: (2013) -
Disposition of Erlotinib and Its Metabolite OSI420 in a Patient with High Bilirubin Levels
por: Czejka, M., et al.
Publicado: (2013) -
A Case of Malignant Peripheral Nerve Sheath Tumor with Rhabdomyoblastic Differentiation: Malignant Triton Tumor
por: Mae, Kenichiro, et al.
Publicado: (2013) -
Laparoscopic Gastrectomy for Gastric Cancer with Peritoneal Dissemination after Induction Chemotherapy
por: Tsutsumi, Satoshi, et al.
Publicado: (2013)